XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Interim Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Income Statement [Abstract]    
Research and development expenses, net $ 587 $ 496
General and administrative expenses 1,329 1,019
Operating loss (1,916) (1,515)
Financing income (expenses), net (**) [1] (45) 33
Net loss $ (1,961) $ (1,482)
Net loss per share, basic and diluted $ (0.48) $ (0.50)
Weighted-average number of common shares outstanding, basic and diluted (*) [2] 4,086,223 2,763,573
[1] The Company adopted ASU 2017-11 using the full retrospective approach. Refer to Note 5 for further information.
[2] March 31, 2018 share data represents the number of shares adjusted to retroactively reflect the 1:15 reverse stock split effected on September 4, 2018. Refer to Note 1 for further information.